Skip to Main Content
  • Korean
  • English
  • Linde Worldwide
  • 린데그룹
  • About Linde
  • Careers
  • Glossary
  • 헬스케어

  • 홈
  • 린데 헬스케어 소개
      • 미션
      • 의료 전문가 지원
      • 환자 중심 치료
      • 혁신적인 지원
        • 헬스케어 혁신
        • 린데 헬스케어와의 파트너십
        • 린데 헬스케어 리얼펀드(REALfund)
      • 핵심 요인
      • 위치
  • 제품 및 서비스
      • 범주별 제품 및 서비스
        • 의료용 가스
          • 의료용 이산화탄소
          • 의료용 헬륨/산소 혼합 가스
          • 의료용 질소
          • 의료용 공기
          • 의료용 아산화질소
          • 의료용 아산화질소/산소 혼합 가스
          • 의료용 산소
        • 병원 설비
          • 재택 치료 장비(예: 산소 발생기, 마스크)
        • QI 의료용 가스 서비스
      • 질병별 제품 및 서비스
        • 마취
          • Medical air
          • Medical oxygen
          • Medical nitrous oxide
          • Medical nitrous oxide/oxygen mixtures
        • 중환자실
          • Medical helium/oxygen mixtures
          • Medical oxygen
        • 산부인과
          • 산부인과에서의 의료용 아산화질소/산소 혼합 가스
        • 통증
          • 통증 분야에서의 의료용 아산화질소/산소 혼합 가스
      • 치료 분야별 제품 및 서비스
        • 응급 치료
          • 의료용 아산화질소/산소 혼합 가스
          • 의료용 산소
          • 응급 치료에서의 기구 및 부대용품
        • 병원 및 임상
          • Medical air
          • Medical nitrous oxide
          • Medical nitrous oxide/oxygen mixtures
          • 의료용 산소
  • 뉴스&미디어
      • 린데그룹 뉴스
      • Events
        • Events Archive
      • Publications
      • Image Library
      • Media Contacts
  • 연락처
  •  
  • Language
    • Korean
    • English
  • Linde Worldwide
  • 린데그룹
  • About Linde
  • Careers
  • Glossary
  • 뉴스&미디어
  • 린데그룹 뉴스
  • Events
  • Publications
  • Image Library
  • Media Contacts
  • 뉴스&미디어
  • 린데그룹 뉴스
  • 2011-05-03 Linde builds large hydrogen and synthesis gas plant in China

Linde builds large hydrogen and synthesis gas plant in China

Trade News

  • Joint on-site project with Chongqing Chemical & Pharmaceutical Holding Company

  • Investment value: around EUR 200 million

  • Market position in China further strengthened

 

Munich, 3 May 2011 – The technology company The Linde Group will build and operate a large hydrogen and synthesis gas plant in the Chongqing Chemical Park in Western China in a joint enterprise with Chongqing Chemical & Pharmaceutical Holding Company (CCPHC). The project has a total investment value of around EUR 200 million. Linde holds 60 percent of the shares in the joint enterprise with CCPHC.

In future, the new on-site plant will provide the production facilities of BASF and CCPHC based in Chongqing with carbon monoxide, hydrogen and synthesis gas.

“We look forward to jointly supporting the expansion of the developing chemical cluster Chongqing with our partner CCPHC,” said Sanjiv Lamba, member of the Executive Board of Linde AG and responsible for the company’s business in Asia.“ As a result of this project, we will further strengthen our position as the leading gases and engineering company in the growth market China.”

The new plant, which will be supplied by Linde’s Engineering Division, is expected to come on stream in the third quarter of 2014.

 

The Linde Group is a world-leading gases and engineering company with around 48,700 employees in more than 100 countries worldwide. In the 2010 financial year, it achieved sales of EUR 12.868 bn. The strategy of The Linde Group is geared towards sustainable earnings-based growth and focuses on the expansion of its international business with forward-looking products and services. Linde acts responsibly towards its shareholders, business partners, employees, society and the environment – in every one of its business areas, regions and locations across the globe. Linde is committed to technologies and products that unite the goals of customer value and sustainable development.

 

For more information, see The Linde Group online at http://www.linde.com

 

Further information:

Press
Uwe Wolfinger
Telephone: +49.89.35757-1320
Investor Relations
Dr Dominik Heger
Telephone: +49.89.35757-1334

Thomas Eisenlohr
Telephone: +49.89.35757-1330
    •  
    • 사이트맵
    • 이용약관
    • 법적공지
    • 정보보호정책
  • © The Linde Group 2016